Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    0(0%)

    Phase Distribution

    Not Applicable
    2
    100%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    N/ANon-phased studies
    2(100.0%)

    Highest Phase Reached

    Unknown

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 1 finished

    Non-Completion Rate

    100.0%

    1 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Terminated(1)
    Other(1)

    Detailed Status

    unknown1
    Withdrawn1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    N/A
    Most Advanced
    N/A

    Trials by Phase

    N/A2 (100.0%)

    Trials by Status

    unknown150%
    withdrawn150%

    Recent Activity

    0 active trials
    Showing 2 of 2
    unknownnot_applicable

    Modified Breath Test to Determine Anabolic Sensitivity Across Physical Activity States

    NCT06209424
    withdrawnnot_applicable

    Two-day Bed Rest, Insulin Sensitivity and Muscle Protein Synthesis

    NCT03877822

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT06209424Not Applicable

    Modified Breath Test to Determine Anabolic Sensitivity Across Physical Activity States

    Unknown
    NCT03877822Not Applicable

    Two-day Bed Rest, Insulin Sensitivity and Muscle Protein Synthesis

    Withdrawn

    All 2 trials loaded

    Drug Details

    Intervention Type
    Behavioral
    Total Trials
    2